Abstract
Antigens derived from various pathogens can readily be synthesized at high levels in plants in their authentic forms. Such antigens administered orally can induce an immune response and, in some cases, result in protection against a subsequent challenge. We here report the expression of rabies virus G protein into carrots. The G gene was subcloned into the pUCpSSrabG vector and then used to transform carrot embryogenic cells by particle bombardment. The carrot cells were selected in liquid medium, a method previously unreported. The presence of the transgene was verified by PCR, and by RT-PCR. By western blot, G protein transgene was identified in 93.3% of adult carrot roots. The G protein was quantified by densitometric analysis (range 0.4–1.2%). The expressed protein was antigenic in mice. This confirms that the carrot is an adequate system for antigen expression.
Similar content being viewed by others
References
Arntzen C (2005) Plant-derived vaccines and antibodies: potential and limitations. Vaccine 23:1753–1756. doi:10.1016/j.vaccine.2005.01.090
Ashraf S, Singh PK, Yada DK, Shahnawaz M, Mishra S, Sawant SV, Tuli R (2005) High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol 119:1–14. doi:10.1016/j.jbiotec.2005.06.009
Astoul E, Lafage M, Lafon M (1996) Rabies superantigen as a Vbeta T-dependent adjuvant. J Exp Med 183:1623–1631. doi:10.1084/jem.183.4.1623
Becker D, Kemper E, Schell J, Masterson R (1992) New plant binary vectors with selectable markers located proximal to the left T-DNA border. Plant Mol Biol 20:1195–1197. doi:10.1007/BF00028908
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 72:248–254. doi:10.1016/0003-2697(76)90527-3
Breitler JC, Labeyrice A, Meynard D, Legavre T (2002) Efficient microproyectile bombardment-mediated transformation of rice using gene cassettes. Theor Appl Genet 104:709–719. doi:10.1007/s00122-001-0786-z
Chambers AP, Duggan SP, Heritae J, Forbes MJ (2002) The fate of antibiotic resistance marker genes in transgenic plant feed material fed to chickens. J Antimicrob Chemother 49:161–164. doi:10.1093/jac/49.1.161
Chen L, Marmey PH, Taylor NJ, Brizard JP, Espinoza C, D’Cruz P, Huet H, Zhang S, Kochko A, Beachy R, Fauquet CM (1998) Expression and inherence of multiple transgenes in rice plants. Nat Biotech 16:1060–1064. doi:10.1038/3511
Cliquet F, Sagné L, Schereffer JL, Aubert MFA (2000) ELISA test for rabies antibody titration in orally vaccinated foxes sampled in the fields. Vaccine 18:3272–3279. doi:10.1016/S0264-410X(00)00127-4
Cuevas RS, Weimersheimer RJ, de Paz VO, Hernández BE, Batalla CD (1996) Utilización del virus rábico de origen vampiro “CASS-88” como cepa de desafío en ovinos. Vet Mex 27:339342
Dean DJ, Abelseth MK, Atanasiu W (1996) The fluorescent antibody test. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies, 4th edn. WHO, Geneva
Delagneau JF, Perrin P, Atanasiu P (1981) Structure of the rabies virus: spatial relationships of the proteins G, M1, M2 and N. Ann Inst Pasteur Virol 132:473–493. doi:10.1016/S0769-2617(81)80036-6
Dhankhar P, Vaidya SA, Fishbein DB, Meltzer MI (2008) Costs effectiveness of rabies post exposure prophylaxis in the United States. Vaccine 26:4251–4255. doi:10.1016/j.vaccine.2008.05.048
Dietzschold B, Wang HH, Rupprecht CE, Celis E, Tollis M, Ertl H, Heber-Katz E, Koprowski H (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci USA 84:9165–9169. doi:10.1073/pnas.84.24.9165
Drings A (1998) Towards a vaccine against the European Lyssaviruses a structural and immunological approach. Freien Universität Berlin, Berlin
Drings A, Jallet C, Chambert B, Tordo N, Perrin P (1999) Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine? Vaccine 17:1549–1557. doi:10.1016/S0264-410X(98)00357-0
Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D (2005) Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 23:1770–1778. doi:10.1016/j.vaccine.2004.11.003
Freuling C, Selhorst T, Bätza HJ, Müller T (2008) The financial challenge of keeping a large region rabies-free- the EU example. Dev Biol (Basel) 131:273–282
Fries LF, Tartaglia J, Taylor J, Kauffman EK, Meignier B, Paoletti E, Plotkin S (1996) Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine 14:428–434. doi:10.1016/0264-410X(95)00171-V
Fu ZF, Dietzschold B, Schumacher CL, Wunner WH, Ertl HC, Koprowski H (1991) Rabies virus nucleoprotein expressed and purified from insect cells is efficacious as a vaccine. Proc Natl Acad Sci USA 88:2001–2005. doi:10.1073/pnas.88.5.2001
Fu X, Duc TL, Fontana S, Bong BB, Tinjuanjun P, Sudhakar D, Twyman MR, Chistou P, Kohli A (2000) Linear transgene constructs lacking vector backbone sequences generate low-copy-number transgenic plants with simple integration patterns. Trans Res 9:11–19. doi:10.1023/A:1008993730505
Hendekli CM (2005) Current therapies in rabies. Arch Virol 150:1047–1056. doi:10.1007/s00705-005-0493-1
Jin-Tao L, Lei F, Zhi-Rong M, Jing W, Yan T, Hai-Yang H, Li W, Yu-Zhang W (2006) Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations. Virology 356:171–178. doi:10.1016/j.virol.2006.07.045
Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala J (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98:11539–11544. doi:10.1073/pnas.191617598
Koprowski H (2005) Vaccines and sera through plant biotechnology. Vaccine 23:1757–1763. doi:10.1016/j.vaccine.2004.11.001
Lontai I (1996) The current state of rabies prevention in Europe. Vaccine 15(Suppl):S16–S19. doi:10.1016/S0264-410X(96)00313-1
Marquet-Blouin E, Bouche FB, Steinmetz A, Muller CP (2003) Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)—derived measles virus hemagglutinin. Plant Mol Biol 51:459–469. doi:10.1023/A:1022354322226
Mason HS, Ball JM, Arzen CJ (1992) Expression of hepatitis B surface antigen transgenic plants. Proc Natl Acad Sci USA 93:11745–11749. doi:10.1073/pnas.89.24.11745
Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93:5335–5340. doi:10.1073/pnas.93.11.5335
McGarvey PB, Hammond J, Dienelt MM, Hooper CD, Fu FZ, Dietzschold B, Koprowski H, Michaels HF (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology 13:1484–1487. doi:10.1038/nbt1295-1484
Modelska A, Dietzschold B, Sleysh N, Fu FZ, Steplewski K, Hooper CD, Koprowski H, Yusibov V (1998) Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci USA 95:2481–2485. doi:10.1073/pnas.95.5.2481
Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plant 15:473–497. doi:10.1111/j.1399-3054.1962.tb08052.x
Orciari AL, Niezgoda M, Hanlon C, Shaddock HJ, Sanderlin WD, Yager AP, Rupprecht EC (2001) Rapid clearance of SAG-2 rabies virus from dogs alters oral vaccination. Vaccine 19:4511–4518. doi:10.1016/S0264-410X(01)00186-4
Paolazzi CC, Pérez O, De Filipo J (1999) Rabies vaccine. Mol Biol 11:137–147
Perea-Arango I, Loza-Rubio E, Roja-Anaya E, Olivera-Flores T, González de la Vara L, Gómez-Lim MA (2008) Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune response in mice. Plant Cell Rep 27:677–685. doi:10.1007/s00299-007-0324-9
Perrin P, Thibodeau L, Sureau P (1985) Rabies immunosomes (subunit vaccine structure and immunogenicity). Pre- and post-exposure protection studies. Vaccine 3:325–332. doi:10.1016/S0264-410X(85)90224-5
Quiambao PB, Dimaano ME, Ambas C, Davis R, Banshoff A, Malerczik C (2005) Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 23:1709–1714. doi:10.1016/j.vaccine.2004.09.027
Rigano MM, Walmsley MA (2005) Expression systems and developments in plant-made vaccines. Immunol Cell Biol 83:271–277. doi:10.1111/j.1440-1711.2005.01336.x
Rosales-Mendoza S, Soria-Guerra RE, Olivera-Flores MTJ, López-Revilla R, Argüello-Astorga GR, Jiménez-Bermont JF, de la Cruz-García RF, Loyola-Rodriguez JP, Alpuche-Solís AG (2007) Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in carrots (Daucus carota L.) protects mice against cholera toxin challenge. Plant Cell Rep 26:969–976. doi:10.1007/s00299-007-0310-2
Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solís AG (2008) Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 27:79–84. doi:10.1007/s00299-007-0439-z
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York
Streatfield SJ (2005) Plant-based vaccines for animal health. Rev Sci Tech 24:189–199
Streatfield SJ (2006) Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150–157. doi:10.1016/j.ymeth.2005.09.013
Streatfield SJ, Lane RJ, Brooks AC, Barker KD, Poage LM (2003) Corn as a production system for human and animal vaccines. Vaccine 21:812–815. doi:10.1016/S0264-410X(02)00605-9
Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302–305. doi:10.1086/315653
Tae-Jin K, Nguyen-Hoang L, Mi-Ok J, Yong-Suk J, Young-Sook K, Jo-Eun S, Moon-Sik Y (2003) Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Trans Res 12:682–691
Wang Y, Xiang Z, Pasquini S, Erlt HC (1997) The use an E1-deleted, replication defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. J Vilol 71:3677–3683
Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC, Koprowski H (1997) Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA 94:5784–5788. doi:10.1073/pnas.94.11.5784
Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, Deka D, Karasev A, Cox S, Randall J, Koprowski H (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20:3155–3164. doi:10.1016/S0264-410X(02)00260-8
Acknowledgments
We appreciate comments by Dr. George M. Baer and the technical assistance of Luis Jorge Saucedo-Arias and Maria de Jesús Jiménez Villalobos. This research was supported by a CONACyT grant (G34635B) to E.L.R and a scholarship to E.R.A. (no.17885). We also thank to Dr. Susan Nadin-Davis (ADRI, Canada), for donating the G protein cDNA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rojas-Anaya, E., Loza-Rubio, E., Olivera-Flores, M.T. et al. Expression of rabies virus G protein in carrots (Daucus carota). Transgenic Res 18, 911–919 (2009). https://doi.org/10.1007/s11248-009-9278-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11248-009-9278-8